IP Verse

Binding Molecules Specific For Cd73 And Uses Thereof

Patent No. EP3218406 (titled "Binding Molecules Specific For Cd73 And Uses Thereof") was filed by Medimmune on Nov 9, 2015. The application was issued on Oct 2, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ROTHDec 23, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSENov 12, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSENov 12, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3218406

MEDIMMUNE
Application Number
EP15791298A
Filing Date
Nov 9, 2015
Status
Patent Maintained As Amended
Aug 30, 2024
Publication Date
Oct 2, 2024
External Links
Slate, Register , Google Patents